Click here for new submission guidelines and trainings effective 1/1/12
Federal
oversight of the academic health center (AMC) research enterprise has
expanded in recent years, in part, to some well publicized incidents in
research involving human subjects. Regulations cover an increasingly
broad spectrum of research operations and touch all research processes
from human subjects to budgeting, billing and reimbursement.
There are no signs that the intensity of the regulatory environment is abating. Rather, governmental rules and regulations are multiplying. Along with other AMC, Lifespan leaders view compliance as an ongoing and evolving function particularly with regards to clinical trials.
Compliance programs for clinical trials comprise multiple elements that include budgeting, billing, training, auditing and monitoring. One of the most critical areas of concern is the billing of services for subjects in clinical trials. In response Lifespan is in the process of creating a new clinical trials billing process with the addition of the newly created position of “Manger Clinical Trial Billing Compliance," who can be reached at dtemple@lifespan.org
Clinical Trial Billing issues apply only to studies that involve human subjects
and consist of more than just survey activities, chart review, or the creation of a
limited data set.
If your study does not have human subjects, or consists only of surveys, chart
review or limited data sets, then you do not need to be concerned with these
billing rules.
For all other studies with human subjects, if you can answer “YES” to the
questions below, then you must apply the Clinical Trials Billing rules to the items/procedures that are performed as part of the study.
167 Point Street
Providence, RI 02903
401-444-3500 | Email Us
Terms of Use |
Privacy
Corporate Compliance
©2013 Lifespan |
Site
Map
Learn about patient safety, quality of care and patient satisfaction at Lifespan.